期刊文献+

非酶糖基化对α-synuclein分子构象的影响 被引量:4

Nonenzymatic Glycation of α-Synuclein and Changes in Its Conformation
下载PDF
导出
摘要 将纯化后的α-synuclein分别与果糖和葡萄糖孵育,通过内源荧光、非酶糖基化衍生物特征荧光、圆二色光谱以及电子显微镜等技术进行检测发现:α-synuclein与还原糖共同孵育后,308nm内源荧光强度明显降低,同时在447nm产生一个非酶糖基化衍生物特征荧光.与果糖孵育的蛋白质样品其非酶糖基化特征荧光的出现速度快于葡萄糖孵育样品.内源荧光与非酶糖基化特征荧光之间存在能量传递现象,提示Tyr残基与非酶糖基化特征荧光发色团在空间距离上彼此接近.圆二色光谱测定结果显示,α-synuclein与果糖孵育后,其α-螺旋含量增加.非酶糖基化的α-synuclein在电子显微镜下表现为短纤维状.非酶糖基化可以诱导α-synuclein蛋白分子聚集,且果糖较葡萄糖更容易使α-synuclein发生非酶糖基化.以上结果提示,非酶糖基化似乎可以导致α-synuclein在细胞内的错误折叠和分子聚集. During the incubation of purified α-synuclein with fructose or glucose, it was observed that the protein intrinsic fluorescence at 308 nm decreased while the fluorescence of glycated derivant at 447 nm increased. This fluorescence representing nonenzymatic glycation of α-synuclein was more rapidly formed in the presence of fructose than that of glucose. Interestingly, an energy transfer could be observed from the intrinsic fluorescence to the nonenzymatic glycating fluorescence, suggesting a near distance between Tyr residues and the nonenzymatic glycated derivant. Experiments using circular dichroism showed that the content of α-helix of nonenzymatic glycated α-synuclein was increased during the nonenzymatic glycation, especially incubated with fructose. The nonenzymatic glycated α-synuclein was in some rod-like filaments under the electronic microscope. That is to say, nonenzymatic glycation induces the conformational changes of α-synuclein which is more vulnerable to the nonenzymatic glycation of fructose. It appears that nonenzymatic glycation induces α-synuclein misfolding and probably aggregation in cell.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2008年第10期1202-1208,共7页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金(90206041,30570536) 国家重点基础研究发展计划(973)(2006CB500703) 中国科学院基金(KSCX2-YW-R-119)资助项目~~
关键词 非酶糖基化 α—synuclein 分子构象 特征荧光 错误折叠 分子聚集 神经退行性疾病 nonenzymatic glycation, α-synuclein, molecular conformation, characteristic fluorescence, molecular aggregation, neurodegeneration
  • 相关文献

参考文献30

  • 1Spillantini M G, Schmidt M L, Lee V M, et al. Alpha-synuclein in Lewy bodies. Nature, 1997, 388(6645): 839-840
  • 2Trojanowski J Q, Lee V M. Aggregation of neurofilament and alphasynuclein proteins in lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch Neurol, 1998, 55(2): 151 - 152
  • 3Trojanowski J Q, Lee V M. Parkinson's disease and related neurodegenerative synucleinopathies linked to progressive accumulations of synuclein aggregates in brain. Parkinsonism Relat Disord, 2001,7(3): 247-251
  • 4Kosaka K. Diffuse neurofibrillary tangles with calcifications: a new presenile dementia. J Neurol Neurosurg Psychiatry, 1994, 57 (5): 594-596
  • 5Lavedan C. The synuclein family. Genome Res, 1998, 8(9): 871-880
  • 6Polymeropoulos M H, Lavedan C, Leroy E, et al. Mutation in the alphasynuclein gene identified in families with Parkinson's disease. Science, 1997, 276(5321): 2045-2047
  • 7Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet, 1998, 18(2): 106- 108
  • 8Tofaris G K, Spillantini M G. Physiological and pathological properties of alpha-synuclein. Cell Mol Life Sci, 2007, 64 (17): 2194-2201
  • 9Dawson T M, Dawson V L. Molecular pathways of neurodegeneration in Parkinson's disease. Science, 2003, 302(5646): 819-822
  • 10Dauer W, Przedborski S. Parkinson' s disease: mechanisms and models. Neuron, 2003, 39(6): 889-909

二级参考文献54

  • 1曲梅花,李辉,徐艳娟,赫荣乔.人神经tau蛋白与DNA相互作用[J].生物化学与生物物理进展,2004,31(10):918-923. 被引量:5
  • 2赫荣乔,陈岚,柯莎,王志珍.多因素异常修饰导致体内蛋白质选择性错误折叠和功能丧失的假设[J].生物化学与生物物理进展,2006,33(10):940-941. 被引量:6
  • 3Mitra N,Sinha S,Ramya T N,et al.N-linked oligosaccharides as outfitters for glycoprotein folding,form and function.Trends Biochem Sci.,2006,31 (3):156~163
  • 4Niemela O.Distribution of ethanol-induced protein adducts in vivo:relationship to tissue injury.Free Radic Biol Med,2001,31 (12):1533~1538
  • 5Chen F,David D,Ferrari A,et al.Posttranslational modifications of tau-role in human tauopathies and modeling in transgenic animals.Curr Drug Targets,2004,5 (6):503~515
  • 6Kurono Y,Ichioka K,Ikeda K.Kinetics of the rapid modification of human serum albumin with trinitrobenzenesulfonate and localization of its site.J Pharm Sci,1983,72 (4):432~435
  • 7Iberg N,Fluckiger R.Nonenzymatic glycosylation of albumin in vivo.Identification of multiple glycosylated sites.Cell,1986,261(29):13542~13545
  • 8Gu W,Roeder R G.Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.J Pharm Sci,1997,90 (4):595~606
  • 9Li M,Luo J,Brooks C L,et al.Acetylation of p53 inhibits its ubiquitination by Mdm2.J Biol Chem,2002,277 (52):50607 ~50611
  • 10Schwartz D C,Hochstrasser M.A superfamily of protein tags:ubiquitin,SUMO and related modifiers.Trends Biochem Sci,2003,28 (6):321~328

共引文献27

同被引文献73

引证文献4

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部